Recurrent Stroke Prevention Clinical Outcome Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 5000 participants.
Also called NCT01198496
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 5,000 participants
- Sponsor
- Biomedis International Ltd.
- Registry
-
NCT01198496
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Unknown status
Technical summary
Registry record NCT01198496. Randomized; no masking; primary purpose prevention. Start 2010-10 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Recurrent Stroke Prevention Clinical Outcome Study
- Acronym
- RESPECTS
- Condition
- Hypertension
- Condition
- Stroke
- Condition
- Blood Pressure
- Intervention (Drug)
- Losartan, Losartan and HCTZ, Amlodipine , Spironolactone
- Lead sponsor
- Biomedis International Ltd.
Record details
- Record id
cardio:ct-nct01198496- Content hash
c2e60a8fc31a89f69e731e8fd9fd7770b86ca6989b94c2537dafaaff8fda1610